Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer's Disease.

Kassaar O, Pereira Morais M, Xu S, Adam EL, Chamberlain RC, Jenkins B, James T, Francis PT, Ward S, Williams RJ, van den Elsen J.

Sci Rep. 2017 Feb 23;7:42874. doi: 10.1038/srep42874.

2.

Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.

Bloom J, Metz C, Nalawade S, Casabar J, Cheng KF, He M, Sherry B, Coleman T, Forsthuber T, Al-Abed Y.

J Biol Chem. 2016 Dec 16;291(51):26502-26514. Epub 2016 Oct 28.

PMID:
27793992
3.

Altered Macrophage and Dendritic Cell Response in Mif-/- Mice Reveals a Role of Mif for Inflammatory-Th1 Response in Type 1 Diabetes.

Sánchez-Zamora YI, Juarez-Avelar I, Vazquez-Mendoza A, Hiriart M, Rodriguez-Sosa M.

J Diabetes Res. 2016;2016:7053963. Epub 2016 Sep 6.

4.
5.

Syntaxin 4 Overexpression Ameliorates Effects of Aging and High-Fat Diet on Glucose Control and Extends Lifespan.

Oh E, Miller RA, Thurmond DC.

Cell Metab. 2015 Sep 1;22(3):499-507. doi: 10.1016/j.cmet.2015.07.023.

6.

The macrophage migration inhibitory factor protein superfamily in obesity and wound repair.

Kim BS, Pallua N, Bernhagen J, Bucala R.

Exp Mol Med. 2015 May 1;47:e161. doi: 10.1038/emm.2015.26. Review.

7.

Serum macrophage migration inhibitory factor levels in Hashimoto's thyroiditis; a case control study.

Ayaz T, Sahin SB, Sahin OZ, Cure MC, Sumer F, Ilkkilic K.

Thyroid Res. 2014 Dec 5;7(1):11. doi: 10.1186/s13044-014-0011-1. eCollection 2014.

8.

Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of β-cell.

Tan L, Ye X, Zhou Y, Yu M, Fu Z, Chen R, Zhuang B, Zeng B, Ye H, Gao W, Lin Q, Li Z, Zhou Q, Chen R.

J Transl Med. 2014 Apr 7;12:92. doi: 10.1186/1479-5876-12-92.

9.

The role of MIF in type 1 and type 2 diabetes mellitus.

Sánchez-Zamora YI, Rodriguez-Sosa M.

J Diabetes Res. 2014;2014:804519. doi: 10.1155/2014/804519. Epub 2014 Jan 2. Review.

10.

MIF deficiency does not alter glucose homeostasis or adipose tissue inflammatory cell infiltrates during diet-induced obesity.

Conine SJ, Cross JV.

Obesity (Silver Spring). 2014 Feb;22(2):418-25. doi: 10.1002/oby.20555. Epub 2013 Sep 17.

11.

Control of tumor-associated macrophage alternative activation by macrophage migration inhibitory factor.

Yaddanapudi K, Putty K, Rendon BE, Lamont GJ, Faughn JD, Satoskar A, Lasnik A, Eaton JW, Mitchell RA.

J Immunol. 2013 Mar 15;190(6):2984-93. doi: 10.4049/jimmunol.1201650. Epub 2013 Feb 6.

12.

Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine-induced apoptosis in vitro.

Stojanovic I, Saksida T, Nikolic I, Nicoletti F, Stosic-Grujicic S.

Clin Exp Immunol. 2012 Aug;169(2):156-63. doi: 10.1111/j.1365-2249.2012.04607.x.

13.

Novel anti-inflammatory activity of epoxyazadiradione against macrophage migration inhibitory factor: inhibition of tautomerase and proinflammatory activities of macrophage migration inhibitory factor.

Alam A, Haldar S, Thulasiram HV, Kumar R, Goyal M, Iqbal MS, Pal C, Dey S, Bindu S, Sarkar S, Pal U, Maiti NC, Bandyopadhyay U.

J Biol Chem. 2012 Jul 13;287(29):24844-61. doi: 10.1074/jbc.M112.341321. Epub 2012 May 29.

14.

Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases.

Kasama T, Ohtsuka K, Sato M, Takahashi R, Wakabayashi K, Kobayashi K.

Arthritis. 2010;2010:106202. doi: 10.1155/2010/106202. Epub 2010 Dec 26.

15.

Macrophage migration inhibitory factor-knockout mice are long lived and respond to caloric restriction.

Harper JM, Wilkinson JE, Miller RA.

FASEB J. 2010 Jul;24(7):2436-42. doi: 10.1096/fj.09-152223. Epub 2010 Mar 10.

16.

Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities.

Kleemann R, Bucala R.

Mediators Inflamm. 2010;2010:610479. doi: 10.1155/2010/610479. Epub 2010 Feb 9. Review.

17.

Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.

Meyer-Siegler KL, Cox J, Leng L, Bucala R, Vera PL.

Cancer Lett. 2010 Apr 1;290(1):49-57. doi: 10.1016/j.canlet.2009.08.025. Epub 2009 Sep 16.

18.

Heat shock protein 27 overexpression mitigates cytokine-induced islet apoptosis and streptozotocin-induced diabetes.

Dai T, Patel-Chamberlin M, Natarajan R, Todorov I, Ma J, LaPage J, Phillips L, Nast CC, Becerra D, Chuang P, Tong L, de Belleroche J, Wells DJ, Wang Y, Adler SG.

Endocrinology. 2009 Jul;150(7):3031-9. doi: 10.1210/en.2008-0732. Epub 2009 Mar 26.

19.

Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function.

Filip AM, Klug J, Cayli S, Fröhlich S, Henke T, Lacher P, Eickhoff R, Bulau P, Linder M, Carlsson-Skwirut C, Leng L, Bucala R, Kraemer S, Bernhagen J, Meinhardt A.

J Biol Chem. 2009 Mar 20;284(12):7977-85. doi: 10.1074/jbc.M808620200. Epub 2009 Jan 20.

20.

Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation.

Santos LL, Dacumos A, Yamana J, Sharma L, Morand EF.

Clin Exp Immunol. 2008 May;152(2):372-80. doi: 10.1111/j.1365-2249.2008.03639.x. Epub 2008 Mar 12.

Supplemental Content

Support Center